Meniscus

Feinstein Institutes’ Daniel A. Grande Named President-Elect of the International Cartilage Regeneration & Joint Preservation Society (ICRS)

Retrieved on: 
Thursday, April 18, 2024
Health, Hospitals, Other Health, Other Science, General Health, Research, Science, Education, FDA, Rheumatology, EVS, Microsoft Exchange Server, Intervertebral disc, Regenerative medicine, Seminal vesicles, Cartilage, Doctor of Philosophy, B cell, Meniscus, ICRS, Patient, Tissue engineering, Molecular medicine, 3D bioprinting, Medical research, Microsoft Access, Multimedia, Regeneration, Stem cell, Credit, Journal, Medical device

The International Cartilage Regeneration & Joint Preservation Society (ICRS) has named Daniel A. Grande, PhD, assistant vice president of research services and professor of molecular medicine and orthopedic surgery at The Feinstein Institutes for Medical Research , its new President-Elect.

Key Points: 
  • The International Cartilage Regeneration & Joint Preservation Society (ICRS) has named Daniel A. Grande, PhD, assistant vice president of research services and professor of molecular medicine and orthopedic surgery at The Feinstein Institutes for Medical Research , its new President-Elect.
  • View the full release here: https://www.businesswire.com/news/home/20240418363701/en/
    Feinstein Institutes’ Dr. Daniel A. Grande has been named the new president-elect of International Cartilage Repair Society.
  • (Credit: Feinstein Institutes)
    Dr. Grande, renowned for his significant contributions to cartilage repair and regeneration, will lead the ICRS in its mission to advance science and education in preventing and treating cartilage injuries.
  • "I am honored and excited to serve as the President-Elect of the International Cartilage Regeneration & Joint Preservation Society.

Arthrex Wins Both Gold and Silver Medals at 2024 Edison Awards

Retrieved on: 
Friday, April 19, 2024
Orthopedic surgery, MIS, Trauma, Invention, Extremities, Surgeon, Gold, Meniscus, Minimally invasive procedure, Patient, Edison Awards, Elective surgery, Thomas Edison, Marketing, Film industry

NAPLES, Fla., April 19, 2024 /PRNewswire/ -- Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards .

Key Points: 
  • NAPLES, Fla., April 19, 2024 /PRNewswire/ -- Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards .
  • The MIS FiberTak® Achilles SpeedBridge™ Repair Implant System with Knotless Rip-Stop won Gold in the Surgical Innovations category.
  • That same year, Arthrex also won three gold awards for OrthoPedia , the InternalBrace™ 2.0 ligament augmentation repair system and for Nano arthroscopy.
  • The 2024 Edison Awards were presented on Thursday, April 18 at the Luminary Hotel and the Caloosa Sound Convention Center in Fort Myers, Florida.

Tacoma Resident Files Lawsuit Against City Following Devastating Incident with Police Vehicle, According to Osborn Machler

Retrieved on: 
Monday, January 22, 2024
Professional Services, Law Enforcement, Emergency Services, Public Policy, Government, Public Safety, State, Local, Legal, Trauma, ACL, Life, City, Superior court, Memory, Abdomen, Pedestrian, Behavior, Rib, Meniscus, Pain, Fear, Running, Lung, Physical disability, Private investigator

Anthony Huff-McKay, a 24-year-old Tacoma resident, today filed a lawsuit against the City of Tacoma following a distressing incident where he was run over and severely injured by a patrol vehicle driven by Tacoma Police Officer Khan Phan.

Key Points: 
  • Anthony Huff-McKay, a 24-year-old Tacoma resident, today filed a lawsuit against the City of Tacoma following a distressing incident where he was run over and severely injured by a patrol vehicle driven by Tacoma Police Officer Khan Phan.
  • According to Austin Neff, an attorney with Osborn Machler who filed the suit on behalf of Huff-McKay, the legal action underscores significant concerns regarding police conduct and emphasizes the urgent need for systemic changes in law enforcement training and accountability.
  • The suit claims the car meet attendees gathered in an intersection and tensions rose as Phan attempted to push through the crowd of pedestrians using his patrol car.
  • “This case is a stark reminder of the grave consequences of inadequate police training and accountability.

Laser Research Optics Introduces Zinc Sulfide Windows that Offer Enhanced Clarity and Scratch-Resistance

Retrieved on: 
Tuesday, November 28, 2023
Zinc sulfide, HIP, Microsoft Windows, Hardness, Sulfide, Meniscus, Ceramic

PROVIDENCE, R.I., Nov. 28, 2023 /PRNewswire-PRWeb/ -- Laser Research Optics has introduced Zinc Sulfide (ZnS) windows that provide enhanced clarity and hardness and can be custom fabricated for military vision and thermal imaging systems requiring optics that perform over a wide wavelength spectrum.

Key Points: 
  • Zinc Sulfide (ZnS) windows that provide enhanced clarity and hardness and can be custom fabricated for military vision and thermal imaging systems requiring optics that perform over a wide wavelength spectrum have been introduced by Laser Research Optics.
  • PROVIDENCE, R.I., Nov. 28, 2023 /PRNewswire-PRWeb/ -- Laser Research Optics has introduced Zinc Sulfide (ZnS) windows that provide enhanced clarity and hardness and can be custom fabricated for military vision and thermal imaging systems requiring optics that perform over a wide wavelength spectrum.
  • Laser Research ZnS Windows are manufactured using Hot Isostatic Pressing (HIP) which provides enhanced clarity, hardness, and scratch-resistance.
  • Laser Research ZnS Windows are priced according to configuration and quantity.

Redwire BioFabrication Facility Successfully Prints First Human Knee Meniscus on ISS, Paving the Way for Advanced In-Space Bioprinting Capabilities to Benefit Human Health

Retrieved on: 
Thursday, September 7, 2023
Biotechnology, Other Manufacturing, General Health, Health, Health Technology, Aerospace, Manufacturing, Other Health, Luther Forest Technology Campus, Biofabrication, RDW, Redwire, Orbit, 3D bioprinting, Tear resistance, BFF, Uniformed Services University of the Health Sciences, Multimedia, Research, International Space Station, Regenerative medicine, Corporation, NASA, University of Texas Health Science Center at San Antonio, LEO, SpaceX, Injury, Meniscus, Scientific research on the International Space Station, Credit, NYSE, ISS, 3D printing, Communications satellite

This milestone opens the door to improved treatments for meniscal injuries, one of the most common injuries for U.S. Service Members.

Key Points: 
  • This milestone opens the door to improved treatments for meniscal injuries, one of the most common injuries for U.S. Service Members.
  • View the full release here: https://www.businesswire.com/news/home/20230907832309/en/
    Redwire’s 3D BioFabrication Facility successfully 3D printed the first human knee meniscus on the International Space Station, paving the way for advanced in-space bioprinting capabilities to benefit human health.
  • (Credit: Redwire)
    “This is a groundbreaking milestone with significant implications for human health,” said Redwire Executive Vice President John Vellinger.
  • Redwire has developed 20 research facilities for the ISS with 10 currently operating on station to deliver world-leading research.

Moximed’s MISHA™ Knee System Treats First Commercial Patients in United States

Retrieved on: 
Wednesday, September 6, 2023
General Health, Health, Medical Devices, Surgeon, University, Terminal, Orthopedic surgery, Oregon Health & Science University, Quality of life, Arthropathy, Hamstring, Cartilage, Trial of the century, Pain, OA, Hospital for Special Surgery, Rehabilitation, Motion, Walking, Standard of care, Patient, Physician, School, SUNY Downstate Health Sciences University, HSS, ISA, Hospital, Ageing, Meniscus, FDA, Chronic pain, Osteoarthritis, University of Virginia, Female, Knee, Dentistry, DRS

Until the MISHA Knee System became available in April 2023, physicians and many patients had limited treatment options when conservative treatments failed.

Key Points: 
  • Until the MISHA Knee System became available in April 2023, physicians and many patients had limited treatment options when conservative treatments failed.
  • Prior to the MISHA Knee System being available, I had no good options for this patient.
  • For these patients, total knee replacement is a reluctant option, as it is an end-stage treatment for end-stage disease.
  • OA patients without end-stage disease seek options that preserve their knee, activity level, and quality of life.

Orthonika awarded £1.34 million Innovate UK grant to accelerate development of its total meniscus replacement towards the clinic

Retrieved on: 
Friday, June 2, 2023
Pain, Osteoarthritis, Entrepreneurship, Innovate UK, Meniscus, Knee, Patient, Imperial College London, Innovation, Doctor of Philosophy, Movement, Pharmaceutical industry, Medical device

LONDON, June 2, 2023 /PRNewswire/ -- Orthonika Limited , a spin-out from Imperial College London, has been awarded a £1.34 million grant from Innovate UK, the UK's innovation agency, to complete pre-clinical development and testing of its synthetic total meniscus replacement in preparation for the clinic.

Key Points: 
  • LONDON, June 2, 2023 /PRNewswire/ -- Orthonika Limited , a spin-out from Imperial College London, has been awarded a £1.34 million grant from Innovate UK, the UK's innovation agency, to complete pre-clinical development and testing of its synthetic total meniscus replacement in preparation for the clinic.
  • Where suture repair is not possible, the injured part or remaining meniscus is removed (meniscectomy) to alleviate symptoms in the short term.
  • "We are delighted that Innovate UK has recognised the potential for our novel total meniscus replacement to fulfil a significant unmet clinical need and further promote joint preservation."
  • This is the fifth Innovate UK grant awarded to Orthonika, bringing total grant funding to £2 million.

FDA Authorizes Marketing of MISHA™ Knee System for People Suffering from Knee Osteoarthritis

Retrieved on: 
Tuesday, April 11, 2023
General Health, FDA, Medical Devices, Health, Health Technology, Duke University, I, Disease, Surgeon, Terminal, American Sports Medicine Institute, Arthritis, Arthroplasty, Quality of life, Cartilage, Multimedia, Doctor of Philosophy, Trial of the century, Pain, OA, Hospital for Special Surgery, TKA, Standard of care, Patient, ISA, Joint, Hospital, Meniscus, Chronic pain, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Hip, Safety, Food, Knee, Pharmaceutical industry

Moximed , a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced that the U.S. Food and Drug Administration (FDA) granted marketing authorization of the MISHA™ Knee System, an implantable shock absorber (ISA) for the knee.

Key Points: 
  • Moximed , a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced that the U.S. Food and Drug Administration (FDA) granted marketing authorization of the MISHA™ Knee System, an implantable shock absorber (ISA) for the knee.
  • View the full release here: https://www.businesswire.com/news/home/20230410005434/en/
    “I've been lucky enough to have been exposed to many major orthopedic innovations, most notably total knee arthroplasty (TKA).
  • For these patients, total knee replacement is a reluctant option, as it is an end-stage treatment for end-stage disease.
  • OA patients without end-stage disease seek options that preserve their knee, activity level, and quality of life.

3D Bioprinter to Print Human Meniscus on the ISS

Retrieved on: 
Thursday, March 9, 2023
United States national laboratories, SpaceX, Health, ISS National Lab, Therapy, BFF, CRS, Meniscus, Research, International Space Station, SPACE, Blood, Heart, Drug discovery, Organoid, Patient, Medial knee injuries, Risk, Knee, Arthritis, Commercial Resupply Services, ISS, Cartilage, Drug development, Joint, Printing, Redwire, Temperature, Tissue engineering, Scientific research on the International Space Station, 3D printing, Pharmaceutical industry

Now that the BFF is installed, it is ready to flex its printing muscles with the facility's first task: producing a full-sized, 3D printed human meniscus.

Key Points: 
  • Now that the BFF is installed, it is ready to flex its printing muscles with the facility's first task: producing a full-sized, 3D printed human meniscus.
  • The investigation to print a full human meniscus will build on previous research from 2019, when the BFF printed cardiac tissue and a partial meniscus.
  • "So right when you print it, you're already closer to human tissue than you would be if you started out trying to print a heart."
  • The facility can be used to print and culture organoids, which resemble human organs but are artificially made.

Heart Muscle Tissue Chips Among Life Science Investigations Launching to ISS on SpaceX CRS-27

Retrieved on: 
Wednesday, March 8, 2023
Redwire, SpaceX, Boeing, ISS National Lab, Stanford University, BFF, CRS, Meniscus, Research, Bangladesh Technical Education Board, 3D bioprinting, Crystallization, Biotechnology, International Space Station, SPACE, Heart, Tissue, Partnership, Kennedy Space Center Launch Complex 39A, Kennedy Space Center, Patient, Johns Hopkins University, Commercial Resupply Services, Skeletal muscle, ISS, National Center for Advancing Translational Sciences, Medicine, Bristol Myers Squibb, Temperature, Knowledge, Scientific research on the International Space Station, United States Commercial Service, MassChallenge, NIH, National Center for Research Resources, Pharmaceutical industry, Communications satellite, 3D printing, Science

These projects, sponsored by the ISS National Laboratory, will study microgravity's effects on engineered heart muscle tissue, and results could lead to new treatments for heart disease.

Key Points: 
  • These projects, sponsored by the ISS National Laboratory, will study microgravity's effects on engineered heart muscle tissue, and results could lead to new treatments for heart disease.
  • These projects were funded through the Tissue Chips in Space initiative , a multiyear collaboration between the ISS National Lab and NIH's National Center for Advancing Translational Sciences.
  • Muscles, including the heart, can weaken in microgravity, so heart muscle tissue chips in space could be used to model heart disease and screen potential new drugs.
  • These are only a few of the investigations sponsored by the ISS National Lab that are launching on this mission.